Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.61 |
| ▸ | USP2 | O75604 | 2/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | ALDH1A2 | O94788 | 1/20 | 0.36 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.36 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | CNR1 | P21554 | 1/20 | 0.34 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9247132 | 0.97 | ALDH1A1 (0.58) | ALDH1A1USP2MAPTMEN1KMT2A | |
| SCHEMBL6732293 | 0.81 | ALDH1A1 (0.64) | ALDH1A1USP2MAPTMEN1KMT2A | |
| SCHEMBL2880184 | 0.80 | ALDH1A1 (0.56) | ALDH1A1USP2MAPTMEN1KMT2A | |
| SCHEMBL14618454 | 0.78 | USP2 (0.67) | ALDH1A1USP2MAPTMEN1KMT2A | |
| SCHEMBL10476199 | 0.77 | USP2 (0.65) | ALDH1A1USP2MAPTMEN1KMT2A | |
| SCHEMBL2871448 | 0.77 | ALDH1A1 (0.52) | ALDH1A1USP2MAPTMEN1KMT2A | |
| SCHEMBL8895535 | 0.76 | USP2 (1.00) | ALDH1A1USP2MAPTMEN1KMT2A | |
| SCHEMBL14602775 | 0.76 | USP2 (1.00) | ALDH1A1USP2MAPTMEN1KMT2A | |
| SCHEMBL3871043 | 0.76 | USP2 (1.00) | ALDH1A1USP2MAPTMEN1KMT2A | |
| SCHEMBL16798146 | 0.75 | ALDH1A1 (0.56) | ALDH1A1USP2MAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1229940-A1 | TEMPERATURE-CONTROLLED AND PH-DEPENDANT SELF-GELLING BIOPOLYMERIC AQUEOUS SOLUTION | BIO SYNTECH CANADA INC. (CA) | 2002-08-14 | — | — | EP | claimed |
| WO-2001036000-A1 | TEMPERATURE-CONTROLLED AND PH-DEPENDANT SELF-GELLING BIOPOLYMERIC AQUEOUS SOLUTION | BIO SYNTECH CANADA, INC. (CA) | 2001-05-25 | — | — | WO | claimed |
| EP-0579138-B1 | Process and reagent for specifically determining LDL in specimens from serum | BOEHRINGER MANNHEIM GMBH (DE) | 1998-10-21 | — | — | EP | claimed |
| CN-111398605-B | Glycosylated hemoglobin measurement composition | 龟甲万株式会社 | 2024-04-05 | — | — | CN | disclosed |
| WO-2024073718-A1 | LOW DOSE IL-6 FORMULATIONS AND METHODS OF USE THEREOF | Sonnet BioTherapeutics, Inc. (US) | 2024-04-04 | — | — | WO | disclosed |
| WO-2023230620-A1 | IL-12-ALBUMIN-BINDING DOMAIN FUSION PROTEIN FORMULATIONS AND METHODS OF USE THEREOF | Sonnet BioTherapeutics, Inc. (US) | 2023-11-30 | — | — | WO | disclosed |
| US-20210063346-A1 | ELECTRO-BLOTTING DEVICES, SYSTEMS, AND KITS AND METHODS FOR THEIR USE | Thermo Fisher Israel Ltd. (IL) | 2021-03-04 | — | — | US | disclosed |
| WO-2020223565-A1 | ANTI-IL-6 ANTIBODY FORMULATION | CORVIDIA THERAPEUTICS, INC. (US) | 2020-11-05 | — | — | WO | disclosed |
| EP-2598515-B1 | TANDEM PURIFICATION OF PROTEINS | PFIZER (US) | 2016-09-21 | — | — | EP | disclosed |
| EP-2598515-A1 | TANDEM PURIFICATION OF PROTEINS | Pfizer Inc (US) | 2013-06-05 | — | — | EP | disclosed |
| WO-2012014183-A1 | TANDEM PURIFICATION OF PROTEINS | PFIZER INC. (US) | 2012-02-02 | — | — | WO | disclosed |
| US-20050019399-A1 | Oral administering; mixture of amorphous drug and polymer; carvedilol | EGALET LTD. (GB) | 2005-01-27 | — | — | US | disclosed |
| US-20050006239-A1 | Solution phase electrophoresis device, components, and methods | Life Technologies Corporation | 2005-01-13 | — | — | US | disclosed |
| US-20040182723-A1 | Method for measuring by means of chemical sensor, and chemical sensor type measuring apparatus | TANITA CORPORATION (JP) | 2004-09-23 | — | — | US | disclosed |
| EP-1429734-A1 | CONTROLLED RELEASE SOLID DISPERSIONS | Egalet A/S (DK) | 2004-06-23 | — | — | EP | disclosed |
| WO-2003024426-A1 | CONTROLLED RELEASE SOLID DISPERSIONS | EGALET A/S (DK) | 2003-03-27 | — | — | WO | disclosed |
| EP-0876512-A1 | METHODS FOR IDENTIFYING INHIBITORS OF RNA VIRUSES | Viropharma Incorporated (US) | 1998-11-11 | — | — | EP | disclosed |
| WO-1997027334-A1 | METHODS FOR IDENTIFYING INHIBITORS OF RNA VIRUSES | VIROPHARMA INCORPORATED (US) | 1997-07-31 | — | — | WO | disclosed |
| EP-0646130-B1 | SELECTIVE CROSSLINKING OF HEMOGLOBINS BY OXIDIZED, RING-OPENED SACCHARIDES | HEMOSOL INC (CA) | 1996-12-11 | — | — | EP | disclosed |
| US-5253198-A | Three-dimensional optical memory | SYRACUSE UNIVERSITY (US) | 1993-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050006239-A1 | Solution phase electrophoresis device, components, and methods | PROC, RAB5IF, SPECC1L | ALDH1A1 3301/4885USP2 2859/4885MAPT 3091/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.